ALT	Alanine aminotransferase
AST	Aspartate aminotransferase
cAMP	Cyclic adenosine monophosphate
CART	Cocaine-and amphetamine-regulated transcript
ChREBP	Carbohydrate-responsive element-binding protein
CKD	Chronic kidney disease
CVD	Cardiovascular disease
DM	Diabetes mellitus
GGT	Gamma-glutamyl transferase
GLP-1RA	Glucagon-like peptide-1 receptor agonist
IR	Insulin resistance
LDL	Low-Density Lipoprotein
MASLD	Metabolic Dysfunction-Associated Steatotic Liver Disease
MS	Metabolic syndrome
NAFLD	Non-alcoholic fatty liver disease
NCDs	Noncommunicable diseases
NPY/AgRP	Neuropeptide Y/agouti-related peptide
PKA	Protein kinase A
POMC	Proopiomelanocortin
ROS	Reactive oxygen species
SELECT	Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity
SREBP-1c	Sterol regulatory element-binding protein-1c
STEP	Semaglutide Treatment Effect in People with obesity
STROBE	Strengthening the Reporting of Observational Studies in Epidemiology
SUSTAIN	Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes
T2DM	Type 2 diabetes mellitus